Unknown

Dataset Information

0

Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound.


ABSTRACT:

Background

Focused transthoracic echocardiography (fTTE) has emerged as a critical diagnostic tool during the COVID-19 pandemic, allowing for efficient cardiac imaging while minimizing staff exposure. The utility of fTTE in predicting clinical outcomes in COVID-19 remains under investigation.

Methods

We conducted a retrospective study of 2,266 hospitalized patients at Rush University Medical Center with COVID-19 infection between March and November 2020 who received a fTTE. fTTE data were analyzed for association with primary adverse outcomes (60-day mortality) and with secondary adverse outcomes (need for renal replacement therapy, need for invasive ventilation, shock, and venous thromboembolism).

Results

Of the 427 hospitalized patients who had a fTTE performed (mean 62 years, 43% female), 109 (26%) had died by 60 days. Among patients with an available fTTE measurement, right ventricular (RV) dilation was noted in 34% (106/309), 43% (166/386) had RV dysfunction, and 17% (72/421) had left ventricular (LV) dysfunction. In multivariable models accounting for fTTE data, RV dilation was significantly associated with 60-day mortality (OR 1.93 [CI 1.13-3.3], p = 0.016). LV dysfunction was not significantly associated with 60-day mortality (OR 0.95 [CI: 0.51-1.78], p = 0.87).

Conclusions

Abnormalities in RV echocardiographic parameters are adverse prognosticators in COVID-19 disease. Patients with RV dilation experienced double the risk for 60-day mortality due to COVID-19. To our knowledge, this is the largest study to date that highlights the adverse prognostic implications of RV dilation as determined through fTTE in hospitalized COVID-19 patients.

SUBMITTER: Gomez JMD 

PROVIDER: S-EPMC8872842 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound.

Gomez Joanne Michelle D JMD   Zimmerman Allison C AC   du Fay de Lavallaz Jeanne J   Wagner John J   Tung Lillian L   Bouroukas Athina A   Nguyen Tai Tri P TTP   Canzolino Jessica J   Goldberg Alan A   Santos Volgman Annabelle A   Suboc Tisha T   Rao Anupama K AK  

International journal of cardiology. Heart & vasculature 20220225


<h4>Background</h4>Focused transthoracic echocardiography (fTTE) has emerged as a critical diagnostic tool during the COVID-19 pandemic, allowing for efficient cardiac imaging while minimizing staff exposure. The utility of fTTE in predicting clinical outcomes in COVID-19 remains under investigation.<h4>Methods</h4>We conducted a retrospective study of 2,266 hospitalized patients at Rush University Medical Center with COVID-19 infection between March and November 2020 who received a fTTE. fTTE d  ...[more]

Similar Datasets

| S-EPMC8242508 | biostudies-literature
| S-EPMC7755011 | biostudies-literature
| S-EPMC9111769 | biostudies-literature
| S-EPMC7273288 | biostudies-literature
| S-EPMC10774821 | biostudies-literature
| S-EPMC9709024 | biostudies-literature
| S-EPMC10245344 | biostudies-literature
| S-EPMC8989117 | biostudies-literature
| S-EPMC7535809 | biostudies-literature
| S-EPMC7338100 | biostudies-literature